5299.80 -132.60 (-2.44%)
NSE Dec 06, 2021 15:31 PM
Volume: 489.2K
 

5299.80
-2.44%

Highlights:

  • Apollo Hospitals set to acquire a majority stake in 180-bed Excelcare Hospitals in Guwahati.
  • Acquisition strengthens Apollo's leadership position in the city, with a combined capacity now of 400 beds (including the existing hospital)
  • Indicates Group's strong focus on the North East, and intent to provide high quality healthcare across the country
  • Q2 FY22 Consolidated Revenues of Rs 37,171 mio (growth of 35% yoy).
  • Q2 FY22 Consolidated EBITDA (Post Ind AS 116) of Rs 6,150 mio.
  • New Hospitals (excl Proton) reported an EBITDA of Rs 1,277 mio in Q2 FY22 as compared to an EBITDA of Rs 387 mio in Q2 FY21.
  • Proton reported EBITDA (Post Ind AS 116) of Rs 139 mio in Q2 FY22 as compared to EBITDA loss of Rs (19) mio in Q2 FY21.
  • AHLL reported EBITDA (Post Ind AS 116) of Rs 621 mio in Q2 FY22 as compared to EBITDA Rs 213 mio in Q2FY21.
  • Consolidated PAT of Rs 2,478 mio in Q2 FY22,
  • Ind-AS 116 on operating lease impacted reported PBT in Q2FY22 to the extent of Rs 116 mio

 

Result PDF

default
Promoters unpledged 7.87% of shares in last quarter. Total pledge stands at 22.08% of promoter holdings
Recommended
More from Apollo Hospitals Enterprise Ltd.